1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
GlycoNex Incorporation

GlycoNex Incorporation

4168.TWO
GlycoNex IncorporationTW flagTaipei Exchange
26.35
TWD
+0.85
- -
2.96BMarket Cap

Total Valuation

GlycoNex Incorporation carries a market capitalization of 2.96B, placing it among publicly traded companies globally. Its enterprise value stands at 2.57B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.96B
Enterprise Value2.57B

Share Statistics

GlycoNex Incorporation currently has 112.52M shares outstanding.

Shares Outstanding112.52M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 73.70, and the price-to-book ratio stands at 3.34.

PE RatioN/A
PS Ratio73.70
PB Ratio3.34
P/TBV Ratio2.86
P/FCF Ratio-17.26
P/OCF Ratio-16.78

Enterprise Valuation

EV / Sales67.92
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

GlycoNex Incorporation maintains a current ratio of 8.00, meaning it holds 8.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 48.30, indicating elevated leverage, while an interest coverage ratio of -35.49 demonstrates limited ability to service its debt obligations.

Current Ratio8.00
Quick Ratio7.42
Debt / Equity48.30
Debt / EBITDA-1.90
Interest Coverage-35.49

Financial Efficiency

Return on Equity (ROE)-27.81
Return on Assets (ROA)-16.39
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Income Tax1.09M
Effective Tax RateN/A

Stock Price Statistics

GlycoNex Incorporation's stock has gained approximately 12.12766% over the past 52 weeks. The 50-day moving average sits at 24.99, while the 200-day moving average is 24.67.

Beta (5Y)N/A
52-Week Price Change12.12766%
50-Day Moving Average24.99
200-Day Moving Average24.67
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, GlycoNex Incorporation generated 37.86M in revenue and converted that into -235.23M in net income, yielding earnings per share of -2.17. EBITDA reached -249.81M, while operating income came in at -249.81M.

Revenue37.86M
Gross Profit23.51M
Operating Income-249.81M
Pretax Income-234.13M
Net Income-235.23M
EBITDA-249.81M
EBIT-249.81M
Earnings Per Share (EPS)-2.17

Balance Sheet

GlycoNex Incorporation holds 693.27M in cash and equivalents against 474.46M in total debt, resulting in a net debt position of 6.80M. Total book value stands at 834.59M, with working capital of 654.56M providing operational flexibility.

Cash & Cash Equivalents693.27M
Total Debt474.46M
Net Debt6.80M
Equity (Book Value)834.59M
Book Value Per Share7.70
Working Capital654.56M

Cash Flow

GlycoNex Incorporation produced -166.29M in operating cash flow over the past twelve months. After subtracting -4.57M in capital expenditures, free cash flow totaled -170.86M - equivalent to -1.58 per share.

Operating Cash Flow-166.29M
Capital Expenditures-4.57M
Free Cash Flow-170.86M
FCF Per Share-1.58

Margins

GlycoNex Incorporation operates with a gross margin of 62.10, reflecting its pricing power and cost economics. The operating margin of -659.81 and net profit margin of -621.29 provide insight into operational efficiency.

Gross Margin62.10
Operating Margin-659.81
Pretax Margin-618.40
Profit Margin-621.29
EBITDA Margin-659.81

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-15.26
FCF Yield-5.80

Stock Splits

GlycoNex Incorporation's most recent stock split took place on August 12, 2014 with a 10:11 split ratio.

Last Split Date8/12/2014
Split Ratio10:11

Scores

GlycoNex Incorporation posts an Altman Z-Score of 2.66, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.66